Skip to main content

Steris Corp(STE-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low211.23
Day High215.03
Open:212.19
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
KeyBanc Remains a Buy on Steris (STE)
StockStory
Q1 Earnings Highs And Lows: STERIS (NYSE:STE) Vs The Rest Of The Surgical Equipment & Consumables - Diversified Stocks
STE
Tipranks
Piper Sandler Remains a Buy on Steris (STE)
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: SI-Bone (SIBN), Pliant Therapeutics (PLRX) and Steris (STE)
Stock Target Advisor
Stocks Trade Lower as Inflation Spikes 3.8%: Market Analysis for May 12th, 2026
Stocks Trade Lower as Inflation Spikes 3.8%: Market Analysis for May 12th, 2026
Motley Fool
Steris (STE) Q4 2026 Earnings Transcript
StockStory
STE Q1 Deep Dive: Margin Expansion and Service Growth Offset Cost Pressures
STE
StockStory
STERIS (NYSE:STE) Reports Q1 CY2026 In Line With Expectations
STE
GlobeNewswire
STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year
StockStory
What To Expect From STERIS’s (STE) Q1 Earnings
STE
Tipranks
Steris Expands Board, Appoints bioMérieux CEO Pierre Boulud
GlobeNewswire
STERIS Appoints Pierre Boulud to Board of Directors
StockStory
3 Healthcare Stocks Walking a Fine Line
STE
GlobeNewswire
STERIS Announces Dividend of $0.63 per share
StockStory
STERIS (STE): Buy, Sell, or Hold Post Q4 Earnings?
STE
StockStory
1 Profitable Stock for Long-Term Investors and 2 We Brush Off
IPAR
GlobeNewswire
STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026
StockStory
Surgical Equipment & Consumables - Diversified Stocks Q4 Earnings: STERIS (NYSE:STE) Firing on All Cylinders
STE
Tipranks
Steris Extends Former CFO Tokich’s Advisory Role

Profile

STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.